[{"id":"10fadbca-6afb-4d6e-bf07-c6be7e26312d","acronym":"","url":"https://clinicaltrials.gov/study/NCT04645797","created_at":"2021-01-19T20:39:34.971Z","updated_at":"2024-07-02T16:35:56.643Z","phase":"Phase 1","brief_title":"A Dose Escalation Study of APR003 in Patients With Advanced Colorectal Cancer (CRC) With Malignant Liver Lesions","source_id_and_acronym":"NCT04645797","lead_sponsor":"Apros Therapeutics, Inc","biomarkers":" MSI","pipe":" | ","alterations":" MSI-H/dMMR","tags":["MSI"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MSI-H/dMMR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e APR003"],"overall_status":"Completed","enrollment":" Enrollment 11","initiation":"Initiation: 01/20/2021","start_date":" 01/20/2021","primary_txt":" Primary completion: 01/09/2023","primary_completion_date":" 01/09/2023","study_txt":" Completion: 01/09/2023","study_completion_date":" 01/09/2023","last_update_posted":"2023-02-01"}]